Research Site

Hooksett, New Hampshire 03106

1 studies enrolling now · 5 studies all time

What they study most

Breast Cancer, Breast Cancer, Early Breast Cancer, Carcinoma, Locally Advanced Breast Cancer, Metastases, Metastatic Breast Cancer, Neoplasm, Non-small-cell Lung

Studies at this site

• An Adjuvant Endocrine-based Therapy Study of Camizestrant (AZD9833) in ER+/HER2- Early Breast Cancer (CAMBRIA-2) — Recruiting now
• The Evaluation of the Efficacy and Tolerability of FASLODEX (Fulvestrant) and AROMASIN (Exemestane) in Hormone Receptor Positive Postmenopausal Women With Advanced Breast Cancer — Completed
• A Phase 3, Multi-Center Study of Gemcitabine/Carboplatin, With or Without BSI-201, in Patients With ER-, PR-, and Her2-Negative Metastatic Breast Cancer — Completed
• Iressa Expanded Access Program (EAP) — Completed
• A Phase 2 Trial of Standard Chemotherapy, With or Without BSI-201, in Patients With Triple Negative Metastatic Breast Cancer — Completed